Market Cap

Oncopeptides AB Market Capitalization:

kr548.7 Million

SEK as of July 1, 2024

US$51.7 Million

business Oncopeptides AB Company Profile

Oncopeptides AB Main Stock Listing

OMX: ONCO

Market Capitalization History of Oncopeptides AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Oncopeptides AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr696.4 M -34.78%
Jan. 1, 2023 kr1.07 B 14.51%
Jan. 1, 2022 kr932.4 M -93.62%
Jan. 1, 2021 kr14.61 B 9.45%
Jan. 1, 2020 kr13.35 B 2.97%
Jan. 1, 2019 kr12.96 B 51.58%
Jan. 1, 2018 kr8.55 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Oncopeptides AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Oncopeptides AB has the following listings and related stock indices.


Stock: OMX: ONCO

Stock: FSX: OND

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.